| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 172.077 | 0 | 0 | - | - | - | - | - | - | - |
| Total Income - EUR | 172.077 | 0 | 0 | - | - | - | - | - | - | - |
| Total Expenses - EUR | 99.086 | 25.099 | 164 | - | - | - | - | - | - | - |
| Gross Profit/Loss - EUR | 72.991 | -25.099 | -164 | - | - | - | - | - | - | - |
| Net Profit/Loss - EUR | 61.297 | -25.099 | -164 | - | - | - | - | - | - | - |
| Employees | 1 | 1 | 0 | - | - | - | - | - | - | - |
Check the financial reports for the company - Wise Pharma Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 58 | 57 | 0 | - | - | - | - | - | - | - |
| Current Assets | 153.521 | 91.347 | 89.739 | - | - | - | - | - | - | - |
| Inventories | 0 | 1.267 | 1.246 | - | - | - | - | - | - | - |
| Receivables | 22.353 | 6.515 | 6.343 | - | - | - | - | - | - | - |
| Cash | 131.169 | 83.565 | 82.151 | - | - | - | - | - | - | - |
| Shareholders Funds | 88.410 | 62.409 | 61.189 | - | - | - | - | - | - | - |
| Social Capital | 90 | 89 | 88 | - | - | - | - | - | - | - |
| Debts | 65.169 | 28.994 | 28.550 | - | - | - | - | - | - | - |
| Income in Advance | 0 | 0 | 0 | - | - | - | - | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4619 - 4619" | |||||||||
| CAEN Financial Year |
4619
|
|||||||||
Comments - Wise Pharma Srl